• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.

作者信息

Stevens Jonathan R, Wilens Timothy E, Stern Theodore A

出版信息

Prim Care Companion CNS Disord. 2013;15(2). doi: 10.4088/PCC.12f01472. Epub 2013 Mar 28.

DOI:10.4088/PCC.12f01472
PMID:23930227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3733520/
Abstract
摘要

相似文献

1
Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.使用兴奋剂治疗注意力缺陷/多动障碍：临床方法与挑战。
Prim Care Companion CNS Disord. 2013;15(2). doi: 10.4088/PCC.12f01472. Epub 2013 Mar 28.
2
Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.基层医疗中注意缺陷多动障碍的管理：角色与挑战的系统分析
Pediatrics. 2008 Jan;121(1):e65-72. doi: 10.1542/peds.2007-0383.
3
Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.注意力缺陷/多动障碍：病因与药物治疗
Arch Iran Med. 2006 Oct;9(4):374-80.
4
Treatment of attention deficit/hyperactivity disorder in children with CHD.治疗患有 CHD 的儿童注意缺陷/多动障碍。
Cardiol Young. 2021 Jun;31(6):969-972. doi: 10.1017/S1047951120004965. Epub 2021 Feb 1.
5
Predicting substance use disorder using long-term attention deficit hyperactivity disorder medication records in Truven.利用Truven中的长期注意力缺陷多动障碍用药记录预测物质使用障碍。
Health Informatics J. 2020 Jun;26(2):787-802. doi: 10.1177/1460458219844075. Epub 2019 May 19.
6
Faking attention deficit hyperactivity disorder.假装患有注意力缺陷多动障碍。
Innov Clin Neurosci. 2011 Aug;8(8):10-3.
7
Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder.儿童注意力缺陷/多动障碍的诊断与治疗的当前策略
Am Fam Physician. 2009 Apr 15;79(8):657-65.
8
Attention deficit hyperactivity disorder. Epidemiologic, pathophysiologic, diagnostic and treatment perspectives.注意力缺陷多动障碍。流行病学、病理生理学、诊断及治疗展望。
Saudi Med J. 2001 Aug;22(8):666-73.
9
Attention deficit hyperactivity disorder in adults: what the non-specialist needs to know.成人注意力缺陷多动障碍：非专科医生需要了解的内容。
Br J Hosp Med (Lond). 2020 Mar 2;81(3):1-11. doi: 10.12968/hmed.2019.0188. Epub 2020 Mar 16.
10
Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.与缓释混合安非他明盐相比，使用盐酸哌甲酯控释片进行兴奋剂治疗对改善患有注意力缺陷多动障碍的青少年驾驶员驾驶性能的相对益处。
Pediatrics. 2006 Sep;118(3):e704-10. doi: 10.1542/peds.2005-2947.

引用本文的文献

1
Cognitive Impairment in Adult Attention Deficit Hyperactivity Disorder: Clinical Implications and Novel Treatment Strategies.成人注意力缺陷多动障碍中的认知障碍：临床意义与新治疗策略
Clin Pract. 2025 Aug 12;15(8):150. doi: 10.3390/clinpract15080150.
2
Non-pharmacological Approaches to Managing Attention-Deficit Hyperactivity Disorder in Pediatric Populations: A Scoping Review.儿科人群注意力缺陷多动障碍管理的非药物方法：一项范围综述
Cureus. 2025 Jul 13;17(7):e87810. doi: 10.7759/cureus.87810. eCollection 2025 Jul.
3
Prevalence Trends and Patterns of Perinatal ADHD Stimulant Medication Use in British Columbia, Canada.加拿大不列颠哥伦比亚省围产期注意力缺陷多动障碍（ADHD）兴奋剂药物使用的流行趋势与模式
Pharmacoepidemiol Drug Saf. 2025 Apr;34(4):e70129. doi: 10.1002/pds.70129.
4
Neuroimaging as a Tool for Advancing Pediatric Psychopharmacology.神经影像学作为推进儿童精神药理学的工具
Paediatr Drugs. 2025 May;27(3):307-330. doi: 10.1007/s40272-025-00683-9. Epub 2025 Feb 3.
5
Stimulant medications effects in heat-related illness in ADHD patients: a large database study.兴奋剂药物对多动症患者中暑相关疾病的影响：一项大型数据库研究。
Front Psychiatry. 2024 Dec 20;15:1509385. doi: 10.3389/fpsyt.2024.1509385. eCollection 2024.
6
Prevalence and correlates of common mental disorders among participants of the Uganda Genome Resource: Opportunities for psychiatric genetics research.乌干达基因组资源参与者中常见精神障碍的患病率及其相关因素：精神疾病遗传学研究的机遇
Mol Psychiatry. 2025 Jan;30(1):122-130. doi: 10.1038/s41380-024-02665-8. Epub 2024 Jul 14.
7
Impact of COVID-19 pandemic on prescription stimulant use among children and youth: a population-based study.新冠疫情对儿童和青少年处方兴奋剂使用的影响：一项基于人群的研究。
Eur Child Adolesc Psychiatry. 2024 Aug;33(8):2669-2680. doi: 10.1007/s00787-023-02346-x. Epub 2024 Jan 5.
8
The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review.α-2激动剂在儿童注意力缺陷多动障碍中的作用：综述
Neurol Int. 2023 May 22;15(2):697-707. doi: 10.3390/neurolint15020043.
9
Double-Blind, Sham-Controlled Randomized Trial Testing the Efficacy of fMRI Neurofeedback on Clinical and Cognitive Measures in Children With ADHD.双盲、假控制随机试验测试 fMRI 神经反馈对 ADHD 儿童临床和认知测量的疗效。
Am J Psychiatry. 2022 Dec 1;179(12):947-958. doi: 10.1176/appi.ajp.21100999. Epub 2022 Nov 9.
10
Patterns of Medication Prescription among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United States.美国注意力缺陷多动障碍儿童及青少年的药物处方模式
Children (Basel). 2022 Jan 30;9(2):171. doi: 10.3390/children9020171.

本文引用的文献

1
Medication use in US youth with mental disorders.美国患有精神障碍的青年人群中的药物使用情况。
JAMA Pediatr. 2013 Feb;167(2):141-8. doi: 10.1001/jamapediatrics.2013.431.
2
ADHD drugs and serious cardiovascular events in children and young adults.注意缺陷多动障碍药物与儿童和青年严重心血管事件。
N Engl J Med. 2011 Nov 17;365(20):1896-904. doi: 10.1056/NEJMoa1110212. Epub 2011 Nov 1.
3
Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.儿童注意缺陷多动障碍兴奋剂治疗的心血管风险：更新和临床建议。
J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):978-90. doi: 10.1016/j.jaac.2011.07.018. Epub 2011 Sep 3.
4
Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy.奥昔哌汀治疗癫痫合并注意缺陷多动障碍的 I 期适应性研究。
Epilepsy Behav. 2010 Jul;18(3):229-37. doi: 10.1016/j.yebeh.2010.02.022. Epub 2010 May 21.
5
A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder.一项关于哌醋甲酯透皮贴剂对注意缺陷多动障碍儿童上学前功能影响的对照试验。
J Clin Psychiatry. 2010 May;71(5):548-56. doi: 10.4088/JCP.09m05779pur.
6
Plasma methylphenidate concentrations in youths treated with high-dose osmotic release oral system formulation.接受高剂量渗透泵控释口服系统制剂治疗的青少年的血浆哌醋甲酯浓度。
J Child Adolesc Psychopharmacol. 2010 Feb;20(1):49-54. doi: 10.1089/cap.2008.0128.
7
Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.2001-2004 年美国国家健康与营养调查中儿童精神障碍的流行状况和治疗情况。
Pediatrics. 2010 Jan;125(1):75-81. doi: 10.1542/peds.2008-2598. Epub 2009 Dec 14.
8
Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study.兴奋剂能预防患有注意力缺陷多动障碍（ADHD）的青少年出现精神疾病吗？一项为期10年的随访研究。
Pediatrics. 2009 Jul;124(1):71-8. doi: 10.1542/peds.2008-3347.
9
Sudden death and use of stimulant medications in youths.青少年猝死与刺激性药物的使用
Am J Psychiatry. 2009 Sep;166(9):992-1001. doi: 10.1176/appi.ajp.2009.09040472. Epub 2009 Jun 15.
10
Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate.使用哌甲酯治疗的注意缺陷/多动障碍儿童和成人未出现细胞遗传学效应。
Mutat Res. 2009 Jun 18;666(1-2):44-9. doi: 10.1016/j.mrfmmm.2009.03.014. Epub 2009 Apr 9.